Skip to main content
Caplight Logo









PicassoMD

PicassoMD

Private
Bethesda, MarylandHealthcare & Life Scienceshttps://picasso.md/

Last Round

Series A

Sep 17, 2024

Total Funding Raised

$9.4M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

PicassoMD is a healthtech company that provides a platform connecting primary care providers with specialists for real-time clinical decision support, referrals, and care coordination.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Vertical SaaS, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

clinical decision supportcare coordinationreferral managementtelemedicinevalue-based careeConsultphysician consultationcurbside consulthealthcare SaaSaccountable care organizationACOclinical workflowHIPAA compliantreferral leakagevirtual care

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PicassoMD Comparables

Compare PicassoMD with similar companies based on industry and business-model similarity.

PicassoMD comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ConferMED
87%
AristaMD
85%
Thea Health
83%

PicassoMD Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 17, 2024
SeedMay 18, 2023

Key People

Founding team and executive leadership

Reza Sanai

Co-CEO and Founder PicassoMD

Founding Team

Sean Carpenter

Chief Technology Officer

Executive Team

PicassoMD Investors

Notable investors and investment history

PicassoMD investors
InvestorRounds
AAF ManagementSeries A
HumbitionSeed
Goat CapitalSeed
GreycroftSeed, Series A
MetrodoraSeed
Blue Venture FundSeed
Operator PartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Monthly visitors grew 180% MoM, reaching 1.1K.

  • Mar 3, 2026

    Monthly visitors grew 108% MoM.

PicassoMD Filings

Explore SEC and related filing metadata, where available.

PicassoMD filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about PicassoMD's valuation, stock price, and market status.

Is PicassoMD a public or private company?

PicassoMD is a private company.

What is the current stock price of PicassoMD?

PicassoMD is a private company with no public stock price. No recent secondary market data is available.

How much is PicassoMD worth (valuation)?

Valuation information for PicassoMD is not publicly available.

Can I buy PicassoMD stock?

PicassoMD shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was PicassoMD's last funding round?

PicassoMD's most recent funding round was Series A on September 30, 2024.

Who are the main investors in PicassoMD?

Key investors in PicassoMD include AAF Management, Greycroft, Operator Partners, 10X Capital, Sandbox Industries.

Will PicassoMD IPO soon?

No public IPO plans have been announced for PicassoMD.

How can I track PicassoMD secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PicassoMD's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBethesda, Maryland
Employee Range20
Year Founded2019
Last FundingSep 17, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?